MedTrace Logo

Assessing the Safety of an IGY Supplement on the Gut Microbiome

NCT06702280 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-11-22

No results posted yet for this study

Summary

This study is to evaluate whether Muno-IgY is effective in enhancing immune health among adults over a six week period.

Conditions

  • Healthy
  • Microbiome

Interventions

DIETARY_SUPPLEMENT

IgY supplement

Ingesting the immune supplement over the experimental period

Sponsors & Collaborators

  • IGY Immune Technologies & Life Sciences Inc.

    collaborator UNKNOWN

  • Nimble Science Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-28
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06702280 on ClinicalTrials.gov